{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T01:25:28Z","timestamp":1760318728619,"version":"3.32.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.peptides.2005.12.003","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:06:46Z","timestamp":1137697606000},"page":"1507-1513","source":"Crossref","is-referenced-by-count":16,"title":["Partial and full agonism in endomorphin derivatives: Comparison by null and operational model"],"prefix":"10.1016","volume":"27","author":[{"given":"Andr\u00e1s Z.","family":"R\u00f3nai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Al-Khrasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Benyhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Orosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9za","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erzs\u00e9bet","family":"Kat\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"T\u00f3thfalusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2005.12.003_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-0115(02)00257-4","article-title":"The effect of endomorphins on the release of 3H-norepinephrine from rat nucleus tractus solitarii slices","volume":"111","author":"Al-Khrasani","year":"2003","journal-title":"Regul Peptides"},{"key":"10.1016\/j.peptides.2005.12.003_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(01)01014-7","article-title":"Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy","volume":"421","author":"Al-Khrasani","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(24)37585-8","article-title":"Stimulation of guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned \u03bc receptor","volume":"286","author":"Alt","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2005.12.003_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0143-4179(87)90043-6","article-title":"Tyr-d-Ala-(Me)Phe-chloromethyl ketone: a \u03bc-specific affinity label for the opioid receptor","volume":"9","author":"Benyhe","year":"1987","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2005.12.003_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(85)90773-3","article-title":"Novel opioid peptides derived from mitochondrial cytochrome b: cytochrophins","volume":"111","author":"Brantl","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(86)90044-0","article-title":"Novel opioid peptides derived from hemoglobin: hemorphins","volume":"12","author":"Brantl","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1515\/bchm2.1979.360.2.1211","article-title":"Novel opioid peptides derived from casein (\u03b2-casomorpohins) I. Isolation from bovine casein peptone","volume":"360","author":"Brantl","year":"1979","journal-title":"Hoppe-Seyler's Z Physiol Chem"},{"key":"10.1016\/j.peptides.2005.12.003_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.6259732","article-title":"Morphiceptin (Tyr-Pro-Phe-Pro-NH2): a potent and specific agonist for morphine (\u03bc) receptor","volume":"212","author":"Chang","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.peptides.2005.12.003_bib9","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1074\/jbc.271.35.21422","article-title":"Determination of the amino acid residue involved in [3H]\u03b2-funaltrexamine covalent binding in the cloned rat \u03bc opioid receptor","volume":"271","author":"Chen","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2005.12.003_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0196-9781(92)90165-Y","article-title":"Isolation of a novel tetrapeptide with opiate and antiopiate activity from human cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1)","volume":"13","author":"Erchegyi","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2005.12.003_bib11","first-page":"339","article-title":"Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues","volume":"181","author":"Fleming","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2005.12.003_bib12","first-page":"115","article-title":"Pharmacological characterization of receptors: its relation to radioligand-binding studies","volume":"37","author":"Furchgott","year":"1978","journal-title":"Fed Proc"},{"key":"10.1016\/j.peptides.2005.12.003_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1749-6632.1967.tb53817.x","article-title":"Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors","volume":"144","author":"Furchgott","year":"1967","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2005.12.003_bib14","first-page":"265","article-title":"Multiple opioid receptors: ligand selectivity profiles and binding site signatures","volume":"36","author":"Goldstein","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1476-5381.1985.tb11112.x","article-title":"Determination of receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of \u03b2-funaltrexamine","volume":"86","author":"Hayes","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0163-7258(00)00100-5","article-title":"Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists","volume":"88","author":"Horv\u00e1th","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.peptides.2005.12.003_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(98)00117-4","article-title":"Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor","volume":"346","author":"Hosohata","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.pa.26.040186.000423","article-title":"Opioid peptide processing and receptor selectivity","volume":"26","author":"H\u00f6llt","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.peptides.2005.12.003_bib19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0091-3057(85)90112-1","article-title":"Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception","volume":"23","author":"Kastin","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2005.12.003_bib20","series-title":"Peptides 2000","first-page":"823","article-title":"Endomorphin related peptide alcohols: structure\u2013activity studies","author":"Kocsis","year":"2000"},{"key":"10.1016\/j.peptides.2005.12.003_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)38179-0","article-title":"Regulation of opioid receptor activities","volume":"289","author":"Law","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2005.12.003_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/(SICI)1097-0282(1999)51:6<440::AID-BIP6>3.0.CO;2-T","article-title":"Mutational analysis of the structure and function of opioid receptors","volume":"51","author":"Law","year":"1999","journal-title":"Biopolymers (Peptide Sci.)"},{"key":"10.1016\/j.peptides.2005.12.003_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.1988.tb16569.x","article-title":"Estimation of opioid receptor agonist dissociation constants with \u03b2-chlornaltrexamine, an irreversible ligand which also displays agonism","volume":"95","author":"Leff","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1476-5381.1990.tb12088.x","article-title":"Pharmacological estimation of agonist affinity: detection of errors that may be caused by the operation of receptor isomerisation or ternary complex mechanisms","volume":"101","author":"Leff","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0160-5402(90)90066-T","article-title":"Estimation of agonist affinity and efficacy by direct, operational model-fitting","volume":"23","author":"Leff","year":"1990","journal-title":"J Pharmacol Meth"},{"key":"10.1016\/j.peptides.2005.12.003_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/bbrc.2001.6136","article-title":"Side chain modifications change the binding and agonist properties of endomorphin 2","volume":"290","author":"Lengyel","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2005.12.003_bib27","first-page":"197","article-title":"Methods used for the study of opioid receptors","volume":"39","author":"Leslie","year":"1987","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.peptides.2005.12.003_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/267495a0","article-title":"Endogenous opioid peptides: multiple agonists and receptors","volume":"267","author":"Lord","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2005.12.003_bib29","first-page":"517","article-title":"The effect of morphine-and morphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2005.12.003_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1986.tb10202.x","article-title":"The contribution of intrinsic activity to the action of opioids in vitro","volume":"87","author":"Miller","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib31","first-page":"1413","article-title":"A single residue Lys 108 of the \u03b4-opioid receptor prevents the \u03bc-opioid-selective ligand (d-Ala2,N-MePhe4,Gly-ol5)enkephalin from binding to the \u03b4-opioid receptor","volume":"50","author":"Minami","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-3011.1981.tb01993.x","article-title":"Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei","volume":"17","author":"Montecucchi","year":"1981","journal-title":"Int J Peptide Prot Res"},{"key":"10.1016\/j.peptides.2005.12.003_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0014-2999(98)00395-1","article-title":"Characterization of endomorphin-1 and-2 on [35S]GTP\u03b3S binding in the mouse spinal cord","volume":"351","author":"Narita","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(94)01341-W","article-title":"DAMGO, a \u03bc-opioid receptor selective agonist, distinguishes between \u03bc-and \u03b4-opioid receptors around their first extracellular loops","volume":"357","author":"Onogi","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2005.12.003_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0031-6997(24)01416-9","article-title":"The \u03b4-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy","volume":"51","author":"Quock","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.peptides.2005.12.003_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)01308-5","article-title":"Opioids in chronic pain","volume":"429","author":"Przewlocki","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib37","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1073\/pnas.87.12.4836","article-title":"cDNAs encoding [d-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides","volume":"87","author":"Richter","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2005.12.003_bib38","series-title":"Endorphins \u201978","first-page":"237","article-title":"Similarities and differences of opioid receptors in different isolated organs","author":"R\u00f3nai","year":"1979"},{"key":"10.1016\/j.peptides.2005.12.003_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0014-5793(77)80842-9","article-title":"Differential behaviour of LPH-(61\u201391)-peptide in different model systems: comparison of the opioid activities of LPH-(61\u201391)-peptide and its fragments","volume":"74","author":"R\u00f3nai","year":"1977","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2005.12.003_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0024-3205(98)00544-X","article-title":"Diprotin A, an inhibitor of dipeptidyl aminopeptidase IV (EC 3.4.14.5) produces naloxone-reversible analgesia in rats","volume":"64","author":"R\u00f3nai","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2005.12.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(00)02770-0","article-title":"Differential antagonism of endomorphin-1 and emdomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone","volume":"881","author":"Sakurada","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2005.12.003_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)35065-7","article-title":"Endomorphin-1and endomorphin-2 show differences in their activation of \u03bc opioid receptor-regulated G proteins in supraspinal antinociception in mice","volume":"291","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2005.12.003_bib43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1471-4159.1998.70041567.x","article-title":"Endomorphin-stimulated [35S]GTP\u03b3S binding in rat brain: evidence for partial agonist activity at \u03bc-opioid receptors","volume":"70","author":"Sim","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.peptides.2005.12.003_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1471-4159.1986.tb13027.x","article-title":"Kinetics and physical parameters of rat brain opioid receptors solubilised by digitonin and CHAPS","volume":"46","author":"Simon","year":"1986","journal-title":"J Neurochem"},{"year":"1994","series-title":"Statistical methods","author":"Snedecor","key":"10.1016\/j.peptides.2005.12.003_bib45"},{"key":"10.1016\/j.peptides.2005.12.003_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.1998.9395","article-title":"In vitro binding and signaling profile of the novel \u03bc opioid receptor agonist endomorphin 2 in rat brain membranes","volume":"250","author":"Spetea","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2005.12.003_bib47","first-page":"2323","article-title":"The use of drug-receptor affinity measures in the differentation of receptors","volume":"41","author":"Tallarida","year":"1982","journal-title":"Fed Proc"},{"key":"10.1016\/j.peptides.2005.12.003_bib48","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/0024-3205(88)90409-2","article-title":"Pharmacologic methods for the identification of receptors","volume":"43","author":"Tallarida","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2005.12.003_bib49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jlcr.2580190904","article-title":"Preparation of (7,8,19,20-3H)naloxone of high specific activity","volume":"19","author":"T\u00f3th","year":"1982","journal-title":"J Label Comp Radiopharm"},{"key":"10.1016\/j.peptides.2005.12.003_bib50","series-title":"Proceedings of the International Narcotics Research Conference","article-title":"New endomorphin analogues using Dmt in position 1","author":"T\u00f3th","year":"2001"},{"key":"10.1016\/j.peptides.2005.12.003_bib51","unstructured":"T\u00f3th G, T\u00f6mb\u00f6ly Cs, P\u00e9ter A, Biyashev D, Borsodi A, R\u00f3nai A, Przewlocki R. New endomorphin analogues: design, synthesis and biological properties. Peptides, in press."},{"key":"10.1016\/j.peptides.2005.12.003_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(82)90083-8","article-title":"Pharmacological profiles of \u03b2-funaltrexamine (\u03b2-FNA) and \u03b2-chlornaltrexamine (\u03b2-CNA) on the mouse vas deferens preparation","volume":"80","author":"Ward","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2005.12.003_bib53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the \u03bc-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105005784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105005784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:10:11Z","timestamp":1736233811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978105005784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0196978105005784"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2005.12.003","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}